Literature DB >> 12662928

Crystal structure of the alpha1beta1 integrin I domain in complex with an antibody Fab fragment.

Michael Karpusas1, Janine Ferrant, Paul H Weinreb, Amie Carmillo, Frederick R Taylor, Ellen A Garber.   

Abstract

The alpha1beta1 (VLA-1) integrin is a cell-surface receptor for collagen and laminin and has been implicated in biological pathways involved in several pathological processes. These processes may be inhibited by the monoclonal antibody AQC2, which binds with high affinity to human alpha1beta1 integrin. To understand the structural basis of the inhibition we determined the crystal structure of the complex of a chimeric rat/human I domain of the alpha1beta1 integrin and the Fab fragment of humanized AQC2 antibody. The structure of the complex shows that the antibody blocks the collagen binding site of the I domain. An aspartate residue, from the CDR3 loop of the antibody heavy chain, coordinates the MIDAS metal ion in a manner similar to that of a glutamate residue from collagen. Substitution of the aspartate residue by alanine or arginine results in significant reduction of antibody binding affinity. Interestingly, although the mode of metal ion coordination resembles that of the open conformation, the I domain maintains an overall closed conformation previously observed only for unliganded I domains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662928     DOI: 10.1016/s0022-2836(03)00203-1

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design.

Authors:  Louis A Clark; P Ann Boriack-Sjodin; John Eldredge; Christopher Fitch; Bethany Friedman; Karl J M Hanf; Matthew Jarpe; Stefano F Liparoto; You Li; Alexey Lugovskoy; Stephan Miller; Mia Rushe; Woody Sherman; Kenneth Simon; Herman Van Vlijmen
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

2.  Structural basis of activation-dependent binding of ligand-mimetic antibody AL-57 to integrin LFA-1.

Authors:  Hongmin Zhang; Jin-Huan Liu; Wei Yang; Timothy Springer; Motomu Shimaoka; Jia-Huai Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

3.  AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes.

Authors:  Motomu Shimaoka; Minsoo Kim; Edward H Cohen; Wei Yang; Nathan Astrof; Dan Peer; Azucena Salas; Audrey Ferrand; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

4.  Stable coordination of the inhibitory Ca2+ ion at the metal ion-dependent adhesion site in integrin CD11b/CD18 by an antibody-derived ligand aspartate: implications for integrin regulation and structure-based drug design.

Authors:  Bhuvaneshwari Mahalingam; Kaouther Ajroud; José Luis Alonso; Saurabh Anand; Brian D Adair; Alberto L Horenstein; Fabio Malavasi; Jian-Ping Xiong; M Amin Arnaout
Journal:  J Immunol       Date:  2011-11-16       Impact factor: 5.422

5.  Dynamic structural changes are observed upon collagen and metal ion binding to the integrin α1 I domain.

Authors:  Paul H Weinreb; Sheng Li; Sharon X Gao; Tong Liu; R Blake Pepinsky; Justin A Caravella; Jun H Lee; Virgil L Woods
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

6.  Magnesium Activates Microsecond Dynamics to Regulate Integrin-Collagen Recognition.

Authors:  Ana Monica Nunes; Conceição A S A Minetti; David P Remeta; Jean Baum
Journal:  Structure       Date:  2018-06-21       Impact factor: 5.006

7.  Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance.

Authors:  Sheng Li; Hao Wang; Baozhen Peng; Meilan Zhang; Daipong Zhang; Sheng Hou; Yajun Guo; Jianping Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-03       Impact factor: 11.205

8.  Integrin α1 has a long helix, extending from the transmembrane region to the cytoplasmic tail in detergent micelles.

Authors:  Chaohua Lai; Xiaoxi Liu; Changlin Tian; Fangming Wu
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.